Zai Lab’s Bemarituzumab Meets Phase III Endpoint in Gastric Cancer Trial
China-based biotech Zai Lab Ltd (NASDAQ: ZLAB, HKG: 9688) announced that its Phase III FORTITUDE-101...
Hengrui Pharmaceuticals’ Aihengping Gains NMPA Approval for Regional Analgesia
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) announced that it has received marketing approval...
Avistone’s Vebreltinib Wins NMPA Approval for MET-Amplified NSCLC
Beijing Avistone Pharmaceuticals Biotechnology Co., Ltd. announced that its subsidiary Pearl Bio’s c-MET inhibitor vebreltinib...
Hengrui Pharmaceuticals Gains NMPA Approval for Aisuda in Severe Alopecia Areata
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has received additional indication approval from the...
MicroPort NeuroTech’s NUMEN Nest Gains FDA Marketing Approval
China-based MicroPort NeuroTech Limited (HKG: 2172) announced that its NUMEN Nest, an enhanced version of...
BMS Secures FDA Approval for Updated Labels of Breyanzi and Abecma
US major Bristol-Myers Squibb (BMS; NYSE: BMY) announced that the US Food and Drug Administration...
GenScript Receives $213.8M Payment from LaNova for PD-1 Antibody License
China-based GenScript Biotech Corporation (HKG: 1548) announced that it has received a payment of USD...
UCB’s Fenfluramine Shows Positive Results in Phase III GEMZ Study for CDKL5 Deficiency Disorder
Belgium-based biopharma UCB (EBR: UCB) announced positive results from its Phase III GEMZ study, evaluating...
Sunshine Lake Pharma Lists on HKEX via Introduction Method
China-based Sunshine Lake Pharma Co., Ltd. (HKG: 6887) has successfully listed on the Main Board...
MGI Tech Partners with Italy’s Negedia to Advance Genomic Sequencing and Spatial Transcriptomics
China-based gene sequencing specialist MGI Tech Co., Ltd. announced a collaboration with Italy’s Negedia to...
China Proposes Healthcare Security Law to Strengthen Medical Insurance System
China’s National Healthcare Security Administration (NHSA) last week released the “Healthcare Security Law (draft proposal)”,...
QuantumPharm and Pfizer Expand Collaboration on Advanced Molecular Simulation Platform
Shenzhen-based QuantumPharm Inc., known as Xtalpi Inc. (HKG: 2228), has announced an expansion of its...
BlissBio Inc. Files for Hong Kong IPO to Advance Oncology-Focused ADC Pipeline
Hangzhou-based oncology-focused clinical-stage biotech BlissBio Inc. has filed for an initial public offering (IPO) with...
FDA Removes REMS Requirements for BCMA- and CD19-Targeted CAR-T Therapies
The U.S. Food and Drug Administration (FDA) last week announced the removal of Risk Evaluation...
ProFound Therapeutics and Novartis Forge Four-Year Partnership for Cardiovascular Drug Targets
US-based ProFound Therapeutics announced a four-year partnership with Swiss giant Novartis (NYSE: NVS) to discover...
Diagens Biotech’s AI Imaging Platform iMedImage Makes Hong Kong IPO Debut
China-based Hangzhou Diagens Biotechnology Co., Ltd. has filed for an initial public offering (IPO) with...
Pfizer’s Emblaveo Approved by China’s NMPA for Complex Infections
US giant Pfizer Inc., (NYSE: PFE) announced that it has received marketing approval from China’s...
Gilead’s Lenacapavir Approved in Hainan for HIV-1 Pre-Exposure Prophylaxis
US-based Gilead Sciences, Inc. (NASDAQ: GILD) announced that its HIV pre-exposure prophylaxis (PrEP) drug, lenacapavir,...
GenFleet Therapeutics Files for Hong Kong IPO Amid KRAS Inhibitor Success
China-based GenFleet Therapeutics (Shanghai) Inc. has submitted its initial public offering (IPO) application to the...
DK Medtech Partners with Mozarc Medical to Enhance Hemodialysis Access Solutions
Suzhou-based DK Medical Technology Co. Ltd., a developer of vascular intervention balloon products, has entered...